AUCTORES
Globalize your Research
Chat with us
Review Article | DOI: https://doi.org/10.31579/2578-8965/233
1Specialist in Allergy and Immunology from ASBAI Master and PhD student in Clinical Immunology and Allergy at FMUSP
2CEO and President of IMMUNO Group
*Corresponding Author: Maria Angela Amato Vigorito, Specialist in Allergy and Immunology from ASBAI Master and PhD student in Clinical Immunology and Allergy at FMUSP.
Citation: Maria A. Vigorito, Gustavo Pradez, (2024), Dendritic Cells Trained Immunity: A Revolutionary Therapy in Genitourinary Tract infections, J. Obstetrics Gynecology and Reproductive Sciences, 8(6) DOI:10.31579/2578-8965/233
Copyright: © 2024, Maria Angela Amato Vigorito. This is an open-access article distributed under the terms of The Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 02 August 2024 | Accepted: 09 August 2024 | Published: 16 August 2024
Keywords: genitourinary tract infections; urinary tract infections; dendritic cells; trained immunity; immunotherapy
Genitourinary Tract infections (GTI), including both vulvovaginal candidiasis (VVC) and urinary tract infections (UTIs), represent a significant burden on public health, affecting millions of women worldwide. These conditions not only impact the quality of life of patients but also incur high healthcare costs due to the need for recurrent treatment and management of complications. The mainstay of treatment for these conditions has traditionally been antibiotics and antifungals. However, overuse of these medications is linked to antibiotic resistance and adverse effects. Dendritic cell trained immunity is an innovative, state-of-the-art reprogramming therapy that offers a revolutionary approach, especially when conventional vaccines are unavailable or for individuals experiencing recurrent infections. Novel studies have demonstrated that these glycoconjugates induce long-lasting epigenetic changes in dendritic cells (DCs), initiating a trained immunity effect that extends protection against subsequent microbial exposures. The aim of this study is to present the latest evidence on the treatment of recurrent genitourinary tract infections, highlighting the potential of dendritic cell trained immunity as a significant breakthrough in gynecological care. This innovative approach not only represents a shift from traditional treatment methods but also offers hope for more effective and sustainable management of recurrent infections, ultimately improving patient outcomes and reducing the burden on healthcare systems.
Vulvovaginal candidiasis (VVC) remains one of the most frequent infections in women, predominantly caused by Candida albicans [1] RVVC affects approximately 138 million women annually (range 103–172 million) worldwide [1]. It is estimated that up to 75% of women of childbearing age will experience a VVC episode in their lifetime. Of these, about 5 to 20% will face recurrent episodes, defined as three or more infections per year. The highest attack rates are observed in women aged 25 to 34." [2]. This often results in physical discomfort, emotional distress, and high medical costs due to frequent consultations and treatments. The morbidity associated with RVVC can negatively affect women's personal and professional lives, harming their relationships and work performance. Apart from clinical suffering or morbidity, both sporadic and RVVC impose an enormous cost on individual patients and healthcare systems. In high-income countries, the economic burden from lost productivity exceeds $14 billion annually [1].
Similarly, urinary tract infections (UTIs) are bacterial infections that primarily affect the bladder and urethra, and are especially prevalent among women due to the anatomy of the female urinary tract. About 60% of women will have at least one UTI during their lifetime, with 30% to 40% experiencing recurrent rUTIs.
Recurrent UTIs represent a considerable burden for both patients and healthcare systems, potentially leading to severe complications, including pyelonephritis and kidney damage if not properly treated [5]. The indiscriminate use of antibiotics to treat asymptomatic bacteriuria in individuals without risk factors contributes to the emerging crisis of antimicrobial resistance, highlighting the need for more judicious treatment practices [5].
Hundreds of millions of women worldwide suffer from UTIs annually, with significant costs associated with treatment, including medications, laboratory tests, and hospitalizations. Effective prevention and management of these infections are crucial to reducing economic impact and improving patients' quality of life [5].
This article provides a comprehensive overview of genitourinary tract infections, highlighting their epidemiology, economic impact, and current treatment approach limitations. It also discusses advances in trained immunity. A deeper understanding of these aspects is essential for developing effective trained immunity immunotherapy strategies for the prevention and management of genitourinary infections, contributing to the improvement of women's health globally.
1.1 Applications and limitations of antibiotics and antifungals in prophylaxis
The main pathogen remains Candida albicans as the dominant pathogenic species, but the less frequent and the most common being Candida glabrata.
Although not life-threatening, VVC causes severe itching, soreness, vaginal irritation, and interferes with normal sexual relations. These symptoms and manifestations are considerably magnified when attacks are frequent, recurrent, and particularly when the disease is refractory to conventional therapy.
C. albicans or VVC, both as topical and systemic agents [1, 3]. Regimens are available as single-dose and multidose, both by prescription and over the counter.
Physicians have increasingly tolerated and often encouraged self-treatment; a growing practice facilitated by the availability of over-the-counter drugs. Over the past two decades, oral fluconazole has progressively dominated azole consumption due to its efficacy, safety, and availability as a generic product. Additionally, several maintenance regimens of fluconazole are widely used for recurrent vulvovaginal candidiasis (RVVC). For three decades, fluconazole has been the favored drug of choice for treating oral and vaginal (i.e., superficial or mucosal) candidiasis [1].
However, concerns about fluconazole-resistant VVC continue to grow, particularly as resistance to fluconazole is widely recognized in Candida species, notably C. glabrata and C. albicans, though fewer epidemiological studies have addressed this issue [6–8]. Reports indicate that fluconazole resistance is becoming an increasingly significant clinical problem, especially in women with RVVC [8–11].
The implications of refractory vaginitis caused by fluconazole-resistant C. albicans are numerous, leading to chronic and often severe vulvovaginal symptoms, exacerbated by the limited availability of alternative therapeutic options. Although suppressive therapy with fluconazole and antibiotics can maintain control of RVVCs, achieving effective results has become increasingly difficult due to the high levels of resistance to this drug [12].
However, the use of ketoconazole and itraconazole are good options for occasional episodes or suppression; they are not indicated for maintenance treatment due to significant side effects [13].
Urinary tract infections (UTIs) are among the most common health issues globally, particularly impacting women.Often these women rely on long-term antibiotic prophylaxis; however, with the alarming global rise in antibiotic resistance, there is a growing urgency to find alternative antibiotic-free treatment options. The problem is such that the WHO implemented a global action plan in 2015 to tackle antimicrobial resistance [3,4]
1.2 Importance of Innate and Adaptative Immunity
The innate immune response is a crucial factor in the defense against Candida infection. It is responsible for the destruction of the pathogen and functions as a physical barrier against this microorganism. Through morphological alterations, yeasts transform into hyphae and penetrate epithelial cells by two mechanisms: induced endocytosis and active penetration [14].
In addition, macrophages display potent candidacidal activity, producing inflammatory cytokines and chemokines that recruit immune cells to the site of infection. Among the recruited cells, the most important and most potent for the elimination of Candida are neutrophils, which are the only cells capable of successfully inhibiting the germination of yeasts into hyphae [15].
The recognition of pathogen-associated molecular patterns (PAMPs) is a crucial stage in the activation of the rapid immune response. These molecular patterns are recognized by receptors such as the mannose receptor, Toll-like receptors (TLRs), and the dectin-1 receptor. The main TLRs responsible for the recognition of Candida are TLR2 and TLR4, which are bound to the membrane and recognize the constituents of the fungal cell wall [15].
The cell wall of C. albicans is composed of two layers: the outer layer presents mainly O- and N-linked glycoproteins that consist of 80-90% mannose, the inner layer contains skeletal polysaccharides of chitin, β-1,3-glucan, and β-1,6-glucan, which strengthen and model cells. These polysaccharides represent the main PAMPs that are recognized by host receptors (PRRs) [15].
In this process, the C-type lectin receptors (CLRs) are very important as they are responsible for the recognition of β-1,3- glucan and β-1,6-glucan. The most studied β-glucan receptor is dectin-1, which is expressed by monocytes and macrophages. In addition to inducing direct cell activation, dectin-1 also broadens the response by binding to TLR2 and TLR4 [16].
When the infection is not controlled by innate immunity, adaptive immunity begins to act. Dendritic cells (DCs) carry out the presentation of fungal antigens to activate the response of Th cells. The most important cytokines in the evolution of Candida-specific Th cells are IL-17 and IFNγ [16]. Furthermore, the production of IL-17 by Th17 cells is important for host defense. These cells are responsible for recruiting and activating neutrophils, as well as activating epithelial cells and releasing antifungal β-defensins [17].
1.3 β-glucans as Innate and Adaptative Immunity Training Driver
In addition to the benefits observed in the treatment of candidiasis, the application of β-glucan also shows promise in recurrent UTI.
As stated, these carbohydrates play crucial roles in physiology and pathophysiology, such as cell interaction and signaling, inflammation, and pathogen-host adhesion/recognition. Therefore, glycoconjugated polysaccharides are being used as adjuvants, carriers for antigens, and as targets for vaccines and immunostimulants for RVVC and a large spectrum of rUTIs patogens.
An improved understanding of the immune system and identification of specific and relevant polysaccharide structures have led to the development of glycoconjugated vaccines and immunostimulants. Resistance to antibiotics and chemotherapeutics has increased scientific interest in such preventive and therapeutic strategies [18].
One of the most important phases in the development of these strategies is the creation of alternatives to using aluminum- based adjuvants. Among the numerous categories of particulate antigen delivery systems, such as immune-stimulating complexes, liposomes, micro- and nanoparticles, and virus-like particles, Saccharomyces cerevisiae-derived β- glucan holds major relevance. β-1,3- glucans are structurally complex carbohydrates, usually isolated from yeast (Saccharomyces cerevisiae) cell walls. This yeast is characterized by a high glucan content (85% β-1,3-D-glucan polymers) [19].
Polysaccharides such as β-glucan can serve both as immunostimulants and as vector systems for efficient antigen delivery to immune cells. The major β-glucan receptors in mammals are dectin-1 and complement receptor 3 (CR3, CD11b/CD18). It has been reported that stimulation via dectin-1 primes Th1, Th17, and cytotoxic T lymphocyte responses, upregulates cell surface presentation of MHC molecules and co-stimulation molecules, and induces the production of inflammatory cytokines [20].
β-glucans, as smart antigen carriers, enhance immunostimulant responses. An antigen delivery system using antigen- loaded glucan particles has shown strong humoral and cytotoxic T cell immune responses and activation of dendritic cells. Subcutaneous administrations of β-glucan microparticulate formulations produce strong antigen-specific antibody production and T cell responses, including cytokine production (IFN-γ and IL-17a) by CD4+ Th1 and Th17 cells [20].
A Brazilian study showed through several assays that β-glucan may be considered an efficient immunomodulator that triggers an increase in the microbicidal response of neutrophils for both species, Candida albicans and Candida glabrata, isolated from vulvovaginal candidiasis [21].
This effect of β-glucan is consistent with several other studies that reported β-glucan as an immunomodulator that improves the human response to infections [22,23]. Recently, this ability to boost innate immunity as well as enhance adaptive responses has been termed "Trained Immunity", a new concept that open a new horizon for immunostimulants [24]
1.4 Trained Immunity as a New Horizon for Immunostimulants
Trained immunity is an emerging concept linked to the capacity of the innate immune system to develop immunological memory. Repeated encounters between a pathogen and classical innate immune cells trigger cellular changes at epigenetic, transcriptional, and functional levels that accelerate future defense against the same or an unrelated pathogen [24].
Trained immunity enables the immune system with the ability to 'remember' and 'train' cells through metabolic and transcriptional reprogramming, allowing them to provide a faster, more robust, and nonspecific defense against a wide array of pathogens during subsequent encounters. [23].
The efficient regulation of immune homeostasis and the promotion or inhibition of immune responses are required for a balanced response. Trained immunity- based vaccines can serve as potent immune stimuli, helping to clear pathogens from the body through multiple or heterologous effects and conferring protection against both nonspecific and specific pathogens [25].
The concept of trained immunity has been used to guide the development of vaccines and immunostimulants aimed at promoting host resistance against a wide spectrum of pathogens. Trained immunity aims to stimulate broader responses, increasing the nonspecific effector response of innate immune cells (e.g., monocytes/macrophages) to pathogens and harnessing the activation state of dendritic cells to enhance adaptive T cell responses to both specific and unrelated (bystander) antigens [24].
As trained immunity is triggered by pattern recognition receptors (PRRs), these formulations include microbial structures containing suitable PRR-ligands, such as whole inactivated bacteria, bacterial lysates, and organelles. The concept of trained immunity is emerging, and several current anti-infectious vaccines, immunostimulants, and adjuvants already fall into this category [24].
Many studies have been conducted with bacterial and fungal formulations. These formulations confer protection against a broad spectrum of pathogens, such as viruses, through a mechanism mediated by trained immunity. These findings open a new horizon in immunostimulants strategy to develop formulations that fit into the trained immunity category [23].
1.5 Trained Immunity” in genitourinary Tract infections
Dendritic Cells Trained Immunity is a novel, state-of-the-art reprogramming therapy that represents a revolutionary strategy. The capacity of trained immunity to promote responses beyond their nominal antigens is game-changing when conventional vaccines are not available or when recurrent infections arise in susceptible individuals [24].
Recurrent (RUTIs) and recurrent vulvovaginal candidiasis (RVVCs) are major healthcare problems.
with high socio-economic impact. Antibiotic and antifungal prophylaxis for RUTIs and RVVCs remain the gold standard treatments, contributing to the rise of antimicrobial resistance, microbiota alterations, and co-infections. Some progress has been made in the gynecological field. Currently, there are a few available trained immunity formulations. Spain and Brazil are at the forefront with “named patient preparations” [27].
E. coli, P. vulgaris, K. pneumoniae, and E. faecalis are considered to produce the major RUTIs. The development of trained immunity immunostimulants glycoconjugated with mixtures of these microorganisms, consisting of whole-cell heat-inactivated in equal proportions (Escherichia coli 25%, Klebsiella pneumoniae 25%, Proteus vulgaris 25%, and Enterococcus faecalis 25%) targeted to the dendritic cells, was evaluated. These formulations showed clinical efficacy for the prevention of RUTIs and promoted dendritic cells' trained immunity responses on Th1/Th17 and IL-10 immune responses.
Data showed remarkable clinical success for the management of RUTIs in young women and frail elderly. These trained immunity formulations emerge as valuable immunoprophylaxis, contributing to an improvement in patients’ quality of life [27, 28,29,30].
Currently, studies show that glycoconjugates (Saccharomyces cerevisiae) target DCs, increasing allergen uptake, increasing IL-10 production and PD-L1 expression, and promoting the generation of functional allergen-specific Treg cells of FOXP3, both in vitro and in vivo. These tolerogenic features are impaired by aluminum-based adjuvants [26].
Combining the clinical efficacy of two trained immunity formulations, heat- inactivated Candida albicans was mixed with E. coli, P. vulgaris, K. pneumoniae, and E. faecalis in aluminum-freeglycoconjugated immunostimulants. Clinical evidence reports that these mixed formulations imprint human dendritic cells (DCs) with the capacity to polarize potent IFN-γ- and IL-17A-producing T cells and FOXP3+ regulatory T (Treg) cells and also promote metabolic and epigenetic reprogramming in human DCs, which are key molecular mechanisms involved in the induction of trained immunity. Clinical studies uncover immunological mechanisms underlying the potential mode of action of the mixed formulation, revealing its efficacy and clinical relevance as an efficient and suitable approach for concomitant genitourinary tract infections (GUTIs) aligned with the trained immunity immunostimulants strategy [27].
1.5 Conclusions and future perspectives
(rUTIs and recurrent RVVC pose significant healthcare challenges with substantial socio-economic impacts. Traditional antibiotic and antifungal prophylaxis, while standard, contribute to the escalating issues of antimicrobial resistance, microbiota disruption, and co-infections.
As recurrent genitourinary infections continue to account for a significant portion of global infections requiring antibiotics and antifungals, research in this field is intensifying. Recent reviews highlight the potential of new preventative measures in treating these infections, with a particular focus on immunostimulant immunotherapy.
Immunostimulant immunotherapy leverages the patient’s own immune system through trained immunity, a groundbreaking approach that reprograms dendritic cells to enhance immune responses. This revolutionary concept promises to transform the management of recurrent infections by developing.
formulations that align with trained immunity principles.
Combining proven clinical efficacy with the ability to prevent recurrent infections, trained immunity immunostimulants mark a major advancement in the field. Future research should delve deeper into the mechanisms of trained immunity and innovate new immunostimulant formulations, aiming to significantly improve the quality of life for women battling recurrent genitourinary infections.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
